Atlas Trials

Ixazomib Citrate and Rituximab in Treating Patients With Indolent B-cell Non-Hodgkin Lymphoma

Clinical trial NCT02339922 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02339922
Sponsor
University of Washington
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaFollicular LymphomaLymphoplasmacytic LymphomaMantle Cell LymphomaMarginal Zone LymphomaRecurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueRefractory Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid TissueSmall Lymphocytic LymphomaWaldenstrom Macroglobulinemia
Start date
2016-05-19
Primary completion
2024-12-30
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.